Director buying at VIVO Cannabis (VIVO)

Director buying at VIVO Cannabis (V:VIVO)

John Langley Easson, a Director, acquired 175,000 Common Shares on a direct ownership basis at prices ranging from $0.719 to $0.785 between December 5th and 6th, 2018. This represents a $131,750 investment into the company's shares and an account share holdings change of greater than 100%.

VIVO Cannabis is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Vivo Cannabis Inc, formerly ABcann Global Corp, is a Canada-based company engaged in the alternative medicine sector. It is a vertically-integrated, cannabis business with a collection of brands targeting consumer segments and needs across both medical and recreational channels, both in Canada and other international markets. The Company's portfolio includes the following brands: Beacon Medical, a standardized pharma-grade cannabis; Fireside Cannabis, tailored to the social user, as well as Lumina Wellness, a wellness-focused cannabis product line. Its wholly owned subsidiary, Harvest Medicine, is an established medical cannabis clinic. The Company holds production and sales licences from Health Canada, and it operates an indoor cultivation facility in Napanee, Ontario, Canada.